Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(9%)
Results Posted
22%(2 trials)

Phase Distribution

Ph phase_1
1
9%
Ph phase_2
2
18%
Ph not_applicable
7
64%
Ph early_phase_1
1
9%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(9)
Other(1)

Detailed Status

Completed9
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (9.1%)
Phase 11 (9.1%)
Phase 22 (18.2%)
N/A7 (63.6%)

Trials by Status

active_not_recruiting19%
unknown19%
completed982%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11